Organon Analyst Ratings
Organon Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/25/2023 | 104.47% | Piper Sandler | $33 → $32 | Maintains | Overweight |
| 10/11/2023 | 40.58% | Morgan Stanley | $27 → $22 | Maintains | Equal-Weight |
| 09/21/2023 | 78.91% | Barclays | → $28 | Initiates Coverage On | → Overweight |
| 08/09/2023 | 72.52% | Morgan Stanley | $25 → $27 | Maintains | Equal-Weight |
| 05/08/2023 | 59.74% | Morgan Stanley | $26 → $25 | Maintains | Equal-Weight |
| 03/16/2023 | 110.86% | Raymond James | → $33 | Initiates Coverage On | → Outperform |
| 11/04/2022 | 53.35% | Morgan Stanley | $27 → $24 | Maintains | Equal-Weight |
| 10/14/2022 | 59.74% | B of A Securities | $37 → $25 | Downgrades | Neutral → Underperform |
| 10/12/2022 | 72.52% | Morgan Stanley | $35 → $27 | Maintains | Equal-Weight |
| 09/06/2022 | 117.25% | Piper Sandler | $37 → $34 | Upgrades | Neutral → Overweight |
| 08/05/2022 | 136.42% | B of A Securities | $40 → $37 | Downgrades | Buy → Neutral |
| 07/08/2022 | 117.25% | Morgan Stanley | $35 → $34 | Maintains | Equal-Weight |
| 04/27/2022 | 155.59% | Goldman Sachs | → $40 | Initiates Coverage On | → Buy |
| 04/06/2022 | 123.64% | Morgan Stanley | $37 → $35 | Maintains | Equal-Weight |
| 02/22/2022 | 136.42% | Morgan Stanley | $35 → $37 | Maintains | Equal-Weight |
| 10/07/2021 | 123.64% | Piper Sandler | → $35 | Initiates Coverage On | → Neutral |
| 09/01/2021 | 174.76% | B of A Securities | → $43 | Initiates Coverage On | → Buy |
| 08/16/2021 | 123.64% | Morgan Stanley | $33 → $35 | Maintains | Equal-Weight |
| 07/23/2021 | 123.64% | Citigroup | → $35 | Initiates Coverage On | → Buy |
| 07/22/2021 | 123.64% | Citigroup | → $35 | Initiates Coverage On | → Buy |
| 06/15/2021 | 142.81% | JP Morgan | → $38 | Initiates Coverage On | → Neutral |
| 06/11/2021 | 110.86% | Morgan Stanley | → $33 | Initiates Coverage On | → Equal-Weight |
| 06/10/2021 | — | Evercore ISI Group | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 2023年10月25日 | 104.47% | 派珀·桑德勒 | $33→$32 | 维护 | 超重 |
| 2023年10月11日 | 40.58% | 摩根士丹利 | $27→$22 | 维护 | 等重 |
| 2023年09月21日 | 78.91% | 巴克莱 | →$28 | 开始承保 | →超重 |
| 08/09/2023 | 72.52% | 摩根士丹利 | $25→$27 | 维护 | 等重 |
| 05/08/2023 | 59.74% | 摩根士丹利 | $26→$25 | 维护 | 等重 |
| 03/16/2023 | 110.86% | 雷蒙德·詹姆斯 | →$33 | 开始承保 | →跑赢大盘 |
| 11/04/2022 | 53.35% | 摩根士丹利 | $27→$24 | 维护 | 等重 |
| 10/14/2022 | 59.74% | B of A证券 | $37→$25 | 评级下调 | 中性→表现不佳 |
| 10/12/2022 | 72.52% | 摩根士丹利 | $35→$27 | 维护 | 等重 |
| 09/06/2022 | 117.25% | 派珀·桑德勒 | $37→$34 | 升级 | 中性→超重 |
| 08/05/2022 | 136.42% | B of A证券 | $40→$37 | 评级下调 | 购买→中性 |
| 07/08/2022 | 117.25% | 摩根士丹利 | $35→$34 | 维护 | 等重 |
| 04/27/2022 | 155.59% | 高盛 | →$40 | 开始承保 | →购买 |
| 04/06/2022 | 123.64% | 摩根士丹利 | $37→$35 | 维护 | 等重 |
| 02/22/2022 | 136.42% | 摩根士丹利 | $35→$37 | 维护 | 等重 |
| 10/07/2021 | 123.64% | 派珀·桑德勒 | →$35 | 开始承保 | →中性 |
| 09/01/2021 | 174.76% | B of A证券 | →$43 | 开始承保 | →购买 |
| 08/16/2021 | 123.64% | 摩根士丹利 | $33→$35 | 维护 | 等重 |
| 07/23/2021 | 123.64% | 花旗集团 | →$35 | 开始承保 | →购买 |
| 07/22/2021 | 123.64% | 花旗集团 | →$35 | 开始承保 | →购买 |
| 2021/06/15 | 142.81% | 摩根大通 | →$38 | 开始承保 | →中性 |
| 2021/11/06 | 110.86% | 摩根士丹利 | →$33 | 开始承保 | →等重 |
| 2021/10/06 | - | Evercore ISI集团 | 开始承保 | →跑赢大盘 |
What is the target price for Organon (OGN)?
Organon(OGN)的目标价是多少？
The latest price target for Organon (NYSE: OGN) was reported by Piper Sandler on October 25, 2023. The analyst firm set a price target for $32.00 expecting OGN to rise to within 12 months (a possible 104.47% upside). 7 analyst firms have reported ratings in the last year.
Piper Sandler于2023年10月25日报道了Organon(纽约证券交易所代码：OGN)的最新目标价。这家分析公司将目标价定为32美元，预计OGN将在12个月内上涨至(可能上涨104.47%)。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Organon (OGN)?
分析师对Organon(OGN)的最新评级是多少？
The latest analyst rating for Organon (NYSE: OGN) was provided by Piper Sandler, and Organon maintained their overweight rating.
分析师对Organon(纽约证券交易所代码：OGN)的最新评级由Piper Sandler提供，Organon维持其增持评级。
When is the next analyst rating going to be posted or updated for Organon (OGN)?
Organon(OGN)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organon, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organon was filed on October 25, 2023 so you should expect the next rating to be made available sometime around October 25, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Organon的高管和客户交谈，以及收听收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Organon的上一次评级是在2023年10月25日提交的，因此您应该预计下一次评级将在2024年10月25日左右提供。
Is the Analyst Rating Organon (OGN) correct?
分析师评级机构(OGN)正确吗？
While ratings are subjective and will change, the latest Organon (OGN) rating was a maintained with a price target of $33.00 to $32.00. The current price Organon (OGN) is trading at is $15.65, which is out of the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Organon(OGN)评级维持不变，目标价在33.00美元至32.00美元之间。Organon(OGN)目前的交易价格为15.65美元，超出了分析师的预测区间。